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Abstract 
In today’s healthcare environment, there is ample evidence to support early identification of 
disease and implementation of effective treatment to improve patient outcomes. The objectives 
of this clinical intervention were twofold; the implementation of an innovative change within an 
organization, allowing for systematic screening through incorporation of the Mood Disorder 
Questionnaire (MDQ), and evaluation of mental health provider’s willingness to incorporate 
practice change. A pre and post quasi-experimental design evaluated the attitude of providers 
regarding practice change using the Evidence-Based Practice Attitude Scale and the utilization of 
the MDQ following educational intervention. Parametric testing was used to explore 
the relationship between education specific to practice change and the provider's attitude through 
the use of the paired t test. The Chi-square test evaluated the use of the MDQ by clinic healthcare 
providers in relation to an innovative practice change. Results of this study illustrate enhanced 
provider willingness to adopt innovation and increased MDQ use following the intervention. 
Ensuring provider access to screening tools and education during the process of practice change 
provides a strategy for early intervention enhanced willingness to support practice evolution. 
Keywords: MDQ, innovation, provider willingness, EBPAS, practice change 
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The Impact of Education on a Mental Health Provider’s Willingness to Adopt Innovation in the 
Diagnostic Process 
In today’s healthcare environment, there is ample evidence to support early identification 
of disease and implementation of effective treatment to improve patient outcomes. In order to 
accomplish this task it is essential that providers have reliable tools available to them in clinical 
practice that gather psychiatric symptomatology in an efficient manner and willingness to adopt 
innovation. The objectives of this clinical intervention were twofold; the implementation of an 
innovative change within an organization, allowing for systematic screening through 
incorporation of the Mood Disorder Questionnaire (MDQ), and evaluation of mental health 
provider’s willingness to incorporate practice change.   
Background and Significance 
According to the National Institute of Mental Health statistics (NIMH, 2014), there are an 
estimated 43.6 million adults in the United States with any mental illness, representing 18.1% of 
all adults. This data represents nearly 44 million individuals and research completed by the 
NIMH suggests only half this number receive treatment (NIMH, 2002). Despite the prevalence 
of psychiatric disorders, many individuals go without treatment due to being undiagnosed or 
being misdiagnosed (Ali, Teich, & Mutter, 2015). Under-recognition of psychiatric disorders is 
common and results in substantial delay in diagnosis, subsequent initiation of treatment, and 
poorer outcomes (Patel et al., 2015).  
Challenges in the Clinical Setting: Internal Evidence 
 In a community mental health clinic in rural Arizona it is evident that the current process 
of psychiatric evaluation leads to variable results due to differing levels of thoroughness, 
skill/experience, and documentation of symptomatology. Additionally, information gathered 
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through random selection retrospective electronic chart review of 100 charts illustrated that 
collection/documentation of symptomatology is not consistently adequate in regards to 
diagnostic formulation based on the Diagnostic Statistical Manual (DSM-V) symptom criteria 
for diagnostic inclusion. This led to misdiagnosis 25% of the time and subsequent introduction of 
ineffective/inappropriate treatment. Identification of this problem led to consideration of ideas 
that would allow for a more streamlined and evidence-based process by which information is 
gathered, so to assure more reliable/valid results in the diagnostic formulation phase of 
psychiatric treatment. Through direct interview of the administration and clinical staff, it was 
found that outpatient psychiatric providers feel limited in the ability to fully assess individuals 
due to short appointment times, delay in follow-up, and complex interviews that interfere with 
successful information gathering.  
Delay in Treatment 
Explanations for delay in treatment have been attributed to poor detection of the illness, 
misdiagnosis, and initiation of inappropriate treatment (Altamura, 2015). To better explain delay 
in initiation of recommended treatment; Drancourt et al. (2013) propose that delay is often due to 
insufficient awareness of illness, lack of screening, and implementation of appropriate treatment. 
Therefore, to reduce the duration of untreated illness they support aggressive strategies to 
identify disorders including tools to improve diagnostic reliability and instigation of systemic 
screening (Drancourt et al., 2013). One strategy to improve diagnostic reliability and systemic 
screening includes the use of screening tools in combination with the traditional interview as 
they act to facilitate targeted diagnoses, treatment, and provides links to empirical literature 
(Baer and Blais, 2010).  
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Psychiatric questionnaires improve diagnostic accuracy with a standardized approach to 
the collection of pertinent data. The use of screening tools translates into better identification and 
earlier intervention/treatment, providing building blocks to improve quality of service (Barwick, 
Boydell, Cunningham, and Ferguson, 2004). The use of screening tools may contribute to routine 
use of standardized assessment and potentially transform the practice of psychiatry into 
mainstream medicine, improving the quality of care for all psychiatric patients (Ricci, Calugi, 
Miniati, and Fagiolini, 2013). This inquiry led to the clinically relevant PICO question, “In 
patients who present with depression (P), how does using the Mood Disorder Questionnaire in 
addition to clinical assessment (I) compared to clinical assessment alone (C) affect the diagnostic 
accuracy of unipolar versus bipolar depression (0)?” 
Search Strategy 
 Evidence pertaining to the clinical question presented above was obtained by performing 
an extensive search of the following databases: US National Library of Medicine National 
Institutes of Health (PubMed), Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), Psychology Information (PsycINFO), and Cochrane Database of Systematic 
Reviews. Keywords included; psychiatry, screening, diagnosis, bipolar, mood disorder 
questionnaire, and MDQ. Exclusion factors included studies published before 2011, those 
written in a language other than English, protocols, doctoral dissertations, and/or age groups <18 
years old. Studies chosen for inclusion included adult patients, those from other countries, 
pregnancy/postpartum, inpatient and outpatient settings. All of the studies chosen for inclusion 
were required to be well-documented with conclusive evidence of descriptive statistical data 
addressing the reliability of the MDQ in evaluating BD disorder. Data was extracted from each 
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study during the review process and organized in the evidence table for concise analysis 
(Appendix A).  
Evidence Synthesis: Critical Appraisal and Conclusions 
 Twelve studies were chosen for inclusion in this search for evidence. The levels of 
evidence in the selected studies ranged from level I through level III, with one meta-analysis, a 
systemic search, random controlled trials, and cohort studies (Melnyk and Fineout-Overholt, 
2015). Conclusions were drawn from the evidence based on critical evaluation of the study 
populations, settings, and related data analysis (Appendices A & B). The variety of research 
settings, sample of individuals, diagnostic groups, and structured diagnostic interview styles 
provided improved generalizability for application of the MDQ as a systematic part of the 
clinical assessment process.  
 In conclusion, the main goal of this literature review was to determine if addition of the 
MDQ in the clinical assessment process affects the diagnostic accuracy of UPD versus BD 
depression. The reliability and validity of the MDQ in detecting BD is documented throughout 
these articles, with p values <0.001 and 95% confidence intervals, which illustrate statistical 
significance and reliability of the MDQ (Appendix A). The most substantial conclusion is that 
the MDQ is an excellent tool for detecting a recent (hypo)manic episode, screening for BP 
during both pregnancy and postpartum periods, and in detecting previously unrecognized BP 
illness when used within a general population sample (without exclusion of BP illness) 
(Appendices A & B). This information supports the use of the MDQ in a systematic screening 
endeavor during the process of clinical assessment; providing improved diagnostic accuracy, 
treatment implementation, and subsequent patient outcomes. 
Purpose and Rationale 
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The purpose of this project is twofold. First, the goal was to implement the use of the 
MDQ the within diagnostic process as part of an innovative organizational change; thereby 
improving the identification of BD and resultant patient outcomes. The second purpose of this 
project was to evaluate mental health provider’s willingness to incorporate the use of an 
evidence-based tool (MDQ) within the diagnostic process. The project outcome allows 
healthcare providers to have a strategy for early intervention that includes identification of BD 
specific symptoms through use of the MDQ; ultimately supporting accurate diagnosis and timely 
implementation of treatment based on established guidelines.  
EBP Model and Theoretical Framework 
 The ACE Star Model of Knowledge Transformation facilitated the practice 
transformation. This model organizes the concepts of improvement of care, providing a 
framework to organize evidence-based practice (EBP) processes illustrated in five major stages 
of knowledge transformation (Stevens, 2004). Stevens (2004) introduces five stages, which 
include discovery research, evidence summary, translation to guidelines, practice integration, and 
process/outcome evaluation. Discovery research generates knowledge through inquiry and 
research methodologies. Evidence summary allows for synthesis of research knowledge into a 
single meaningful statement that reflects the science. The third step requires translation of the 
evidence into recommendations for practice. The next step requires practice integration to create 
a more sustainable system, involving individual and organizational practices. Process and 
outcome evaluation act as the final step. This stage allows for evaluation of the EBP impact on 
care outcomes, efficacy and efficiency of the practice change, patient/provider satisfaction, and 
other various endpoints (Stevens, 2004). This model provided a foundation for sustained practice 
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change based on evidence-based research, with the intent to enhance patient care through 
improved diagnostics and treatment implementation. 
 The diffusion of innovation theory (DOI) provided the theoretical framework necessary 
to guide this intervention (Rogers, 2003)(Appendix C). This theory offers valuable 
understanding of the process of change, stressing the need for communication within the 
adoption process (Kaminski, 2011). Rogers identified five categories of adopters and described 
their influence on both innovation and adoption of change (Rogers, 2003). Rogers’ theory 
allowed a step-wise guide for adoption of innovation to include the knowledge stage (literature 
search and provider exposure), persuasion stage (education of providers), decision/evaluation 
stage (data analysis), implementation stage (intervention implementation), and the confirmation 
of adoption stage (data analysis and outcome evaluation) ( Kaminski, 2011). 
Purpose Statement 
The evidence gained through extensive literature review supports a systematic change in 
practice, to include the use of the MDQ during the evaluation of patients presenting for 
psychiatric care. Although system change is necessary to provide an improved mechanism for 
data collection and enhanced diagnostic ability, it is imperative that the providers are educated of 
the importance and routinely utilize the knowledge gained from the questionnaire when 
formulating diagnoses. In order to evaluate the efficacy of this intervention, outcomes were 
measured to include systemic use of the MDQ and the provider’s attitude toward an evidence-
based practice change.  
Applying Evidence into Practice: Project Methods 
 Project implementation required evaluation of the environment, project management, and 
change management (Moran, Burson, and Conrad, 2014). Initial evaluation of the environment 
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focused on the setting, the organizational culture, and the stakeholders. Subsequent project 
intervention focused on the innovative change itself, to include related ethics and participants.  
Setting 
 The setting of this project is an outpatient clinic within a rural mental health organization 
in Northern Arizona. The organization was incorporated in March of 1966 and has a long and 
steady history of providing behavioral health services to the local community. The organization 
consists of a staff of just over 200, a budget of approximately $18 million per year, and provides 
some 4,000 individuals with over 150,000 behavioral health services annually.  
Intervention 
  This clinical intervention presents an innovative change in healthcare delivery, requiring a 3-
phase process for completion. The initial phase of this intervention included implementation of 
the practice change, which allowed for systematic screening of individuals that presented for 
psychiatric treatment. Thereby, the MDQ results were available for incorporation in the initial 
diagnostic formulation and subsequent treatment planning. The second phase of the intervention 
focused on education of the organization’s providers at the beginning of the data collection 
phase. Learning objectives included recognition of the prevalence of BD, understanding of the 
diagnostic challenges related to BD, identification of the complications related to delay in 
initiation of treatment, knowledge of the MDQ, and utilization of rating scales to aid the 
diagnosis of BD. The third stage of this intervention focused on the evaluation of the provider’s 
willingness to adopt innovation in the diagnostic process, measured by the Evidence Based 
Practice Attitude Scale (EBPAS). 
Ethics: Protection of Human Subjects and Recruitment 
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In order to assure protection of human subjects during the process of this intervention, 
Arizona State University International Review Board approval was obtained prior to initiation of 
the project and the plan was adhered to in full. Recruitment of the participants occurred at the 
setting described above and during an extension endeavor offered by Health Choice Integrated 
Care, for which institutional support was granted. In order to protect the participants, random 
identification numbers were placed on the initial cover letter, pre-, and post-educational session 
questionnaires. The survey measures were not linked with practitioner identities. No identifying 
data from the patient’s MDQ survey was recorded during this project, as the chart review is only 
intended to assess whether or not the MDQ was completed following the innovative practice 
change.  
Design 
 A pre and post quasi-experimental design evaluated the utilization of the MDQ following 
educational intervention and the attitude of providers regarding practice change using the 
EBPAS. Evaluation included the use of instruments, data collection, and subsequent analysis 
using SPSS® version 23 statistical package. Parametric and Nonparametric tests were used to 
analyze the outcome variables. The critical value was set at p<0.05. 
Instruments  
In order to evaluate the efficacy of this practice change, outcome measurement included 
the use of the Mood Disorder Questionnaire (MDQ) and the provider’s attitude toward an 
evidence-based practice change. Two instruments were used to measure the outcome variables, 
the MDQ and the Evidence-Based Practice Attitude Scale (EBPAS). 
The Mood Disorder Questionnaire. The MDQ scale is a 15-item self-screening 
instrument that aids in the diagnosis of bipolar disorder (see Appendix D). The instrument 
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consists of 3 sections, which include symptom endorsement, symptom clustering, and severity of 
problem caused (Twiss, Jones, and Anderson, 2008). The first section consists of 13 yes/no 
statements; the second section consists of one yes/no question specific to the simultaneous 
occurrence of the symptoms presented; the third section consists of one question concerning the 
influence of the symptoms. To accurately identify the presence of BD, the suggested standard 
cutoff score is 7 or more symptoms with simultaneous occurrence and moderate or greater 
impairment (Wang et al., 2015). The MDQ illustrates a summary sensitivity (.62) and specificity 
(.85) in detection of BD in psychiatric outpatients with a cutoff score of 7 (Wang et al., 2015; 
Hirschfeld et al., 2003). Additionally, Lin et al. (2011) found the internal consistency reliability of 
the tool to be 82% and the context validity index to be 80%. 
Evidence-Based Practice Attitude Scale. The EBPAS was developed to evaluate mental 
healthcare provider’s attitudes towards evidence-based practice (see Appendix E). The scale is a 
15-item Likert Scale that measures openness to innovation and perceived importance of using 
research-based innovations in clinical practice (Aarons, 2004). The first 8 questions review the 
individual’s feelings about using new types of interventions, therapy, or treatment. The last 7 
questions review the individual’s likelihood of adopting innovative treatments if they had 
received training specific to the intervention. The items are broken down into 4 scales, which 
include requirements, appeal, openness and divergence (Aarons, 2004). Subscale scores are 
computed using a mean score for each item set in order to determine the total score. Chronbach’s 
alpha illustrated internal consistency in reliability, ranging from high to moderate (3 items; 
α=0.93), appeal (4 items; α = 0.74), openness (4 items; α=0.81), divergence (4 items; α=0.66), and 
EBPAS Total (15-items; α=0.79) (Aarons, 2004). 
Data Collection  
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The MDQ data was collected once 8 weeks after the MDQ practice change was initiated. 
Data extraction included a retrospective chart review of all new psychiatric evaluations 
completed within the 8-week period prior to intervention and focused on MDQ use by providers, 
provider type, and patient’s primary diagnosis. Post-intervention data was obtained by reviewing 
the charts of individuals with psychiatric evaluations completed within the 8-week period 
subsequent to the intervention. The collection process was identical for audit of pre and post-
intervention data. 
Psychiatric providers were asked to complete the EBPAS prior to the educational session, 
which included demographic questions. Participants then spent 30 minutes in the educational 
intervention prior to completing the post-education EBPAS. The EBPAS allowed for evaluation 
of the provider’s attitude toward the practice change both before and after a 30-minute 
educational session regarding use of the MDQ. The educational session was conducted during the 
medical staff meeting for all staff. Evaluation of EBPAS results illustrated the effectiveness of 
education when implementing innovative change. 
Chart Audit. Chart audit provides a tool for quality improvement that illustrates purpose 
in required measurements, administrative requirements, research, and quality improvement 
(Quality improvement, 2017). Research applications include audits to determine prevalence of 
conditions by taking a snapshot sample to evaluate if processes are being followed (University 
Hospitals Bristol, 2017).  
Data Analysis 
The SPSS® version 23 statistical package was used to analyze the data. Descriptive 
statistics were used to describe the sample and outcome variables. A chi-square test was 
conducted to test the use of the MDQ in relation to the innovative practice change. A chi-square 
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evaluates whether or not two variables are independent of each other (Cronk, 2014). A paired t-
test was used test the provider’s willingness to adopt innovation in practice in relationship to 
education. A paired t-test is a parametric test that allows the comparison of two scores (Keller 
and Kelvin, 2014). The critical value was set at p<0.05. 
Project Results 
The plan for statistical analysis included evaluation of three specific data sets; provider 
demographics, the use of the MDQ pre- and post-implementation of the practice change, and 
evaluation of the EBPAS pre-and post-educational intervention.  
Descriptive statistics were used to evaluate the sample (n=29), that included 8 psychiatric 
providers in a rural mental healthcare organization and 21 additional participants from the 
extension opportunity. The sample (n=29) consisted of 10 (34.5%) psychiatrists, 18 (62.1%) nurse 
practitioners (NPs), and 1 (3.4%) physician’s assistant (PA). The ages were categorized into 4 age 
groups: 18-34 (n=1, 3.4%), 34-54 (n=13, 44.8%), 55-74 (n=11, 37.9%), and 75+ years (n=4, 
13.8%). Years of experience in the psychiatric field were 6-10(n=5, 17.2%), 11-15 (n=9, 31.0%), 
16-20 (n=7, 24.1%), 21-25 (n=2, 6.9%), and 26+ (n=6, 20.7%). The providers were asked if they 
had previously used psychiatric screening questionnaires. Twenty-six (89.7%) of the responders 
answered yes; however, a greater percentage had utilized screening questionnaires, 19 (65.5%) 
had not used the MDQ in practice. The reasons provided were the following: the tool was not 
available (n=12, 44.4%), takes too much time (n=4, 13.8%), or other (n=3, 10.3%). 
 The chart audit consisted of 300 chart reviews; including all new psychiatric evaluations 
within the 8 weeks before and after the intervention. The average age of patients was 31.80 
(SD=19.30) years, 207 (69%) of which were adults and 93 (31%) child or adolescent. Appraisal 
of all new psychiatric evaluations (n=181) completed within the 8 weeks prior to systemic 
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screening implementation illustrated that the MDQ was used in 27 (14.9%) of all evaluations. 
The evaluations were completed by differing provider specialties, to include 2 (1.1%) PAs, 148 
(81.8%) by NPs, and 31 (17.1%) by psychiatrists. The MDQ was not used by the Pas; however, 
it was used in 21 out of 127 (16.5%) evaluations by NPs, and 6 out of 25 (24%) by physicians. 
The chart audits (n=119) following implementation of systematic screening illustrated that the 
MDQ was used in 94 (79%) of the evaluations. Eleven (9.2%) MDQ evaluations were completed 
by physicians and 108 (90.8%) were competed by NPs, illustrating improved MDQ use by NPs 
(78.7%) and physicians (90.9%). A chi-square test of independence was calculated comparing 
the results of MDQ use pre and post-intervention. No significant relationship was found (χ2(1) = 
.575, p< .001). Pre and post-intervention MDQ use appear to be independent events, indicating 
that there is not significant dependence of one variable upon the other (Cronk, 2014). 
A paired t test was used to evaluate the provider’s attitude towards willingness to adopt 
innovation. Analysis compared the average pre and posttest EBPAS domain scores for 
requirement, appeal, openness, and divergence (See Table 1). A paired-samples t test was 
calculated to compare the mean pre-intervention scores to the mean post-intervention scores. The 
mean on the pre-intervention was 40.69 (sd=8.05), and the mean on the post-intervention was 
41.17 (sd=7.57). A significant increase from pretest to posttest was found (t(28)=-1.09), p<.001). 
This demonstrates that education regarding practice change significantly affects provider’s 
willingness to adopt innovation in the practice setting. 
Table 1 
 
Pre and Posttest EBPAS Scores 
                        Pre                         Post   
EBPAS Scale  n         M(SD)     min    max  n M(SD)  min max 
Requirement  29       7.10(4.09)     .00    12.0  29 6.86(4.18) .00 12.0  
Appeal   29       12.00(2.60)   6.0    16.0  29 12.38(2.53) 6.0 16.0  
Openness  29       10.48(3.46)   1.0    15.0  29 11.24(2.77) 3.0 16.0 
Divergence  29       11.10(2.98)   4.0         16.0  29 10.69(2.61) 4.0 16.0 
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Discussion 
This project offers value through both insights and consequences of evidence-based 
practice evolution. Firstly, through the process of a strategic change, innovation can occur within 
the practice setting. This sets the stage for improved patient outcomes through systemic 
screening; ultimately allowing for identification of disorders and more timely treatment 
implementation. Secondly, this project brings about awareness of the importance of provider 
participation in innovative change. The implications of this project are potentially limitless, as it 
indicates that team involvement and education have the potential to enhance the process of 
innovation.  
Limitations 
 This study has several important limitations. The design is a simple pre-post design that 
includes a small sample size. This reduces generalizability and the strength of statistical analysis 
available for use in data evaluation. Another limitation is present within the systemic screening 
endeavor, as paper questionnaires were used. This left room for human error, in that they were not 
given to every patient, nor uploaded to the electronic health record in all cases. Additionally, this 
study does not address the knowledge gained from MDQ use or impact on patient outcomes. 
Future research recommendations include use of larger sample sizes and electronic measures to 
assure more consistency in strategic enactment of change, as well as the impact on patient 
outcomes. 
Sustainability 
 The complex healthcare environment requires evidence-based approaches to care delivery, 
alongside interprofessional collaboration, to assure process sustainment (White, Pillay, and 
Huang, 2016). In order to assure sustainability of this intervention, recommendations include 
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incorporating the use of the MDQ in the electronic medical record, regular auditing of use in the 
diagnostic process, and ongoing educational endeavors to support improved collaboration 
between the evidence and clinical practice.  
Summary 
The practice environment is complex and providers face numerous challenges in 
providing care to patients in an efficient manner. This paper illustrates the need for healthcare 
providers to have a strategy for early intervention that includes identification of bipolar specific 
symptoms through use of the MDQ; ultimately supporting accurate diagnosis and timely 
implementation of treatment based on established guidelines. Additionally, innovation in practice 
is necessary in order to implement best practice findings in a timely fashion. Through 
incorporation of provider education and engagement there is enhanced willingness to adopt 
innovation in the practice setting. This supports improved patient and system-specific outcomes. 
The combined efforts of this innovative practice change have a foundation of evidence-based 
literature subsequently guided by outcome measurement, which acts to ultimately enhance 
provider efficiency and efficacy in the diagnostic process and improve patient outcomes. 
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of the mood disorder 
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screening tool for bipolar 
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O’Sullivan Research 
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Bias: No financial 
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the subject of this article. 
LOE:III 
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Women who were PG 
or PP 
Exclusion Criteria: All 
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(13.3%), MA (58%) 
ED- HS (16.7%), CD 
(27.3), UN (26.7) 
ΨDX- MDD (50.7%), 
AX (17.3%), BP 
(12%), ADJ (9.3%), 
SUB (3.3%), PSYCH 
(2%) 
 
correlation, 0.69-
0.50= fair/fair 
correlation, 
<0.50=poor/poor 
correlation 
(2-6%) is similar to 
bipolar disorder 
(4%), yet providers 
fail to regularly 
screen for BP. 
Boschloo, L. (2013). The 
mood disorder 
questionnaire (MDQ) for 
detecting (hypo)manic 
episodes: Its validity and 
impact of recall bias. 
Population: Adult patient 
recruited from various 
sites, Netherlands. 
Funding: The study was 
supported by participating 
universities and mental 
health care organizations 
Bias: Authors have 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Longitudinal 
research design, 
Intervention study. 
Purpose: to examine 
the validity of the 
MDQ in detecting 
hypomanic episode 
and explore the impact 
of recall bias. 
Inclusion Criteria:PTS 
with DEP or AX DX 
or referred without 
DX. 
 
Sample: data derived 
from the NESDA. 
N=2981 
With DP DX= 2329 
(78%) 
Without DP DX= 652 
(22%) 
Recruited from the 
community (19%), 
Primary care (54%), 
and OP MH (27%) 
Recruited 
IV1-Ψ EVAL 
DV1- Ψ DX A 
DV2- MDQ 
score A 
 
Presence of 
(hypo)mania 
measured with 
CIDI 
MDQ, with 
standard cutoff at 7 
Conducted 
using SPSS 
version 20.0 
Internal 
consistency 
expressed in 
Cronbach’s 
alpha: 
substantial 
(0.81-1.00), 
moderate (0.61-
0.80), fair (0.41-
0.60), slight 
(0.11-0.40) and 
virtually no 
Reliability: 
internal 
consistency 
0.84, cronbachs 
alpha 0.85. 
Validity: 
AUC=0.83, 
95% CI, 
p<0.001, 
SN=0.85, 
SP=0.65 
Standard cutoff 
≥7 showed to 
be optimal with 
SN=0.83 and 
The validity of the 
MDQ for detecting a 
recent (hypo)manic 
episode was 
excellent.  
Standard cutoff point 
≥7 appeared optimal. 
With good SN and 
SP. However, there 
was poor 
performance for 
lifetime episodes. 
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received speaking fees and 
unrestricted grants from 
pharmaceutical companies 
and NOHRD. 
LOE:II 
Exclusion Criteria: 
PTS with primary BP 
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command of the Dutch 
language, incomplete 
EVAL, incomplete 
MDQ data, OCD, 
SUB, PSYCH, or 
ORG. 
Consecutively (0.00-0.10) 
Performance of 
MDQ in 
detecting 
lifetime 
hypomanic 
episode 
examined by 
processing a 
ROC curve. 
SP=0.82 
Gan, Z. (2012). Validation 
of the Chinese version of 
the mood disorder 
questionnaire for screening 
bipolar disorder among 
patient with a current 
depressive episode. 
Population: patients treated 
in the psychiatry 
department, the 3rd 
Affiliated Hospital of Sun 
Yat-sen University. 
Funding: Natural Science 
Foundation of Guangdong 
Province, China. 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Controlled 
Trial- Intervention 
study 
Purpose: Evaluate the 
validity of the Chinese 
version of the MDQ in 
screening BP in PTS 
with current MDE. 
Inclusion Criteria: 
Eligible subjects were 
treated concurrently 
for MDE in the 
psychiatric 
department, who 
provided informed 
N- 142 consecutive 
PTS 
INP=102 (71.8%), 
OP= 40 (28.2%) 
122 completed the 1 
YR FU. 
BPI Group: 
AA=28±8.7, 
OA=25.4±8.2, 
DOI=42.1±34.4, 
F=5(25%), 
AF=6(30%) 
BPII Group: 
AA=29.2±8.6, 
IV1-SCID-1 
IV2-MDQ 
DV1- Initial Ψ 
DX 
DV2- Final Ψ 
DX/ A 
DV3-MDQ 
score/ DX A 
 
Instrument use of 
SCID-I 
MDQ 
Statistical 
analysis using 
SPSS 13.0 
Mann-Whitney 
U and Chi-
square test. 
Cronbach alpha 
used to access 
internal 
consistency. 
ROC curve 
plotted for 
screening 
performance. 
Optimal cutoff 
was determined 
MDQ showed 
good accuracy 
with BP, even 
with cutoff of 4. 
SN=0.72, 
SP=0.73 
Cronbach 
coefficient for 
the MDQ= 
0.735 
BP 
AUC=0.803, 
p<0.001, 
BPI 
AUC=0.826, 
MDQ is more 
sensitive in detecting 
BPI versus BPII.  
MDQ (even without 
section 2 and 3) is a 
valid tool for BPII 
and previously 
unrecognized BPI. 
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Bias: Authors report no 
competing interests 
LOE:III 
consent. 
Exclusion Criteria: 
PTS who declined or 
with a Ψ or physical 
DO that prevented 
them from being 
interviewed or 
undermined their 
ability to provide 
accurate information 
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OA=25.7±9.3, 
DOI=51.8±61.3, 
F=27(54%), AF=8 
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UPD Group: 
AA=33.6±10.5, 
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DOI=30.8±33.0, 
F=29(55.8%), 
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by maxing the 
Youden’s 
index(=SN+SP-
1) 
p<0.001 
BPII 
AUC=0.794, 
p<0.001 
ROC analysis 
illustrated 
improved cutoff 
at 4 and 5, 
illustrating far 
improved SP 
and SN 
Poon, Y. (2011). The use 
of the mood disorder 
questionnaires, hypomanic 
checklist-32 and clinical 
predictors for screening 
previously unrecognized 
bipolar disorder in a 
general psychiatry setting.  
Population: General 
psychiatric setting in Hong 
Kong 
Funding: Not reported 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Randomized 
controlled trial. 
Purpose: examine 
clinical predictors of 
BP an determine the 
best approach for 
screening previously 
unrecognized BP in 
the general population. 
Inclusion Criteria: 
ethnic Chinese, aged 
18-64, no previous DX 
of BP, PSYCH, MR, 
Dementia and AG. 
N=340 
AA=50,Range 18-64 
F=66.8%m M=23.2% 
2/3 MA 
65% =secondary ED 
status or + 
AA illness onset= 37.5 
(range 10-62) 
FHX- 20% 
MDE/MDD and 7.9% 
IV1-BP FHX 
IV2-AOI <21 
DV1- Ψ DX A 
DV2- MDQ 
score/ DX A 
 
MDQ 
HCL-32 
SCID 
SPSS version 
15.0. 
Multivariable 
logistic 
regression. 
Categorical 
variables 
analyzed by chi-
square or 
Fisher’s exact 
text. 
P<0.05 
MDQ SN=0.65, 
SP=0.77,PPV=
0.24, NPR=0.95 
BP FHX 
SN=0.23, 
SP=0.93, 
PPV=0.28, 
NPV=0.91 
MDQ and BP 
FHX SN=0.71, 
SP=0.72, 
PPV=0.22, 
NPV=0.96 
MDQ is a valid and 
reliable screening 
instrument for 
previously 
unrecognized BP. 
Optimal cutoff was 
4+ symptoms. 
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Depression, YR-Year 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
Bias: Not reported 
LOE:II 
Exclusion 
Criteria:Those that did 
not meet inclusion 
criteria. 
BP 
 
Internal 
consistency of 
the MDQ 
determined with 
Cronbach’s 
alpha. 
Internal 
consistency of 
0.75 
Lin, C. (2011). Reliability 
and validity of the Chinese 
version of the mood 
disorder questionnaire.  
Population: PTS receiving 
OP services in a medical 
center in Taiwan. 
Funding: Not Reported 
Bias:Not reported 
LOE:II 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Intervention 
study. Measures 
included Personal 
information 
questionnaire, MINI, 
and MDQ-C 
Purpose: to extend 
previous studies by 
examining the 
psychometric 
properties of the 
MDQ, helping 
professionals to 
identify BP in CP. 
Inclusion Criteria: 
(a)adult PTS, (b) DG 
with a mood disorder 
according to the DSM, 
including Depressive 
DO and BP, (c) able to 
follow instructions for 
N=170  
AA= 38.94 (±13.77). 
F=97 (57.06%) 
M=73 (42.94%) 
Education: 
HS-88.22% 
Diagnosis based on 
MINI: 
BP I-67(39.41%) 
BPII-25 (14.71%) 
BPNOS-3 (1.76%) 
MDD- 75 (44.12%) 
IV1-Ψ MINI 
IV2-MDQ-C 
DV1- Ψ DX A 
DV2- MDQ 
score/ DX A 
 
Personal 
information 
Questionnaire 
(gender, FHX, 
occupation, age). 
MINI 
MDQ 
Cronbach’s 
alpha to 
determine 
reliability. 
Bartlett’s test of 
sphericity and 
Kaiser-Meyer-
Olkin measure 
of sampling 
adequacy 
Internal 
consistency 
reliability= .82 
Context 
Validity index 
80% 
Youden index 
Cutoff 6: 
SN=0.85, 
SP=0.87 
Cutoff 7: 
SN=0.75, 
SP=0.93 
Cutoff 8: 
SN=0.53, 
SP=0.99 
Optimal cutoff 
Psychometric 
property analysis 
illustrated optimal 
cutoff of 6, noting 
that 85% of patients 
with BP will screen 
positive and 87% 
without would be 
ruled out. 
Cross-cultural 
consistency with 
good reliability, 
validity, SN and SP. 
Able to discriminate 
BP from the general 
population. 
Concludes improved 
ability for nursing 
staff to screen, 
identifying mood 
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Depression, YR-Year 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
answering the Q. 
 
Exclusion Criteria: 
Those that did not 
meet inclusion criteria 
or complete the 
screening process. 
6 with 
AUC=0.86 
 
 
disorders in clinical 
practice and 
potentially reduce the 
rate of suicide and 
improved QOL. 
Lee, D. (2013). Usefulness 
of the combined 
application of the mood 
disorder questionnaire and 
the bipolar spectrum 
diagnostic scale in 
screening for bipolar 
disorder.  
Population: Korea, 
psychiatric IP and OP 
settings 
Funding: None reported 
Bias: No bias reported. 
LOE:II 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Controlled 
trial (intervention 
study). MDQ and 
BSDS, with 1 year FU. 
Purpose: examine 
whether combined 
application of the 
MDQ and BSDS is 
more effective than  
either tool in screening 
for BP. 
Inclusion Criteria: Age 
18-65, current MDE 
Exclusion Criteria: 
Patients with MR, 
DEM, PSYCH, severe 
agitation, severe MED 
& ORG. 
Setting: Gyeongsang 
National University 
Hospital between 
3/2009 and 3/2011. 
Sample of IPS and 
OPS experiencing a 
current MDE. 
N=131 
Group 1: BP (N=81, 
AA=35.5 ±11.9 years) 
Group 2:MDD (N=32, 
AA=41.4± 10.6 years) 
No significant 
differences found in 
terms of sex, LOE, or 
IV1- MDQ 
IV2-BSDS   
IV3—Ψ EVAL 
DV1- Ψ DX A 
DV2- MDQ 
score/ DX A 
DV3- BSDS 
score/ DX A 
 
MDQ 
BSDS 
T-tests for 
continuous data 
and chi-square 
tests for 
categorical data 
Two-tailed p-
value<0.05 
SPSS version 
12.0 
Cutoff 6: 
SN=0.741, 
SP=0.844, 
PPV=.923,NPV
=.563 
Cutoff 7: 
SN=0.605, 
SP=0.873 
DG Specific: 
BPI SN=1.00, 
SP0.844 
BPII SN=.643, 
SP=.465 
BPNOS 
SN=.739, 
Increased use in 
primary care and Ψ 
clinics 
recommended. 
Cutoff of 6=best SN 
and SP 
MDQ more effective 
for BPI than BPII 
Combination of 
MDQ and BSDS is 
more effective than 
either alone. 
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Depression, YR-Year 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
MS. SP=.467 
Rybakowski, J. K. (2012). 
Use of the hypomania 
checklist-32 and the mood 
disorder questionnaire for 
detecting bipolarity in 
1,051 patients with major 
depressive disorder.  
Population: Poland 
Funding: Supported by a 
grant provided by Sanofi-
Aventis Poland 
Bias: Authors declare no 
conflict of interest. 
LOE:II 
None Stated. 
Donabedian 
Model 
inferred. 
Design: All Poland 
Multi-Center 
Intervention study 
Purpose: to use the 
HCL-32 and the MDQ 
for detecting bipolarity 
in depressed patients 
Inclusion Criteria: 
diagnosis of MDE or 
MDD (current or past) 
and 18 years or older. 
 
Exclusion Criteria: 
diagnosis of 
dysthymia, BPI, BPII, 
HAM Score over 17, 
treatment with mood-
stabilizing drugs, MR, 
SUB, or severe MED. 
Sample: 150 OP 
clinics, representing 16 
regions of Poland. 
N=1,051 
F=752 
M=299 
Age=18-77 
HCL-32 score=10.3± 
8.0,37.5% reached 
cutoff for BP 
MDQ Score 3.6 ±3.2, 
20% reached cutoff for 
BP 
 
IV1- MDQ 
IV2-HCL-32   
IV3—Ψ EVAL 
IV4-HAM  
DV1- MDQ 
Score/ DX A 
DV2- HCL-32 
Score/ DX A 
Ψ EVAL by trained 
psychiatrist 
MDQ 
HCL-32 
HAM  
STATA 
Statistical 
Software 
Chi2 test, 
Kruskal-Wallis. 
Two-sided with 
significance at 
5%. 
Mean MDQ 
score=3.6±3.2 
(mean± SD). 
Mean HCL-32 
10.3±8.0 
(mean± SD) 
Spearman 
correlation 
coefficient=0.7
7 (p<0.001) 
F:0.75, M:0.81 
PTS TR with 
AD drugs in 
MDQ+ and 
MDQ- =26.4% 
and 12.4% 
Large group of 
depressed patients 
evaluated with 
scales. More than 1/3 
met BP criteria.  
 
Corroborates an 
association between 
refractoriness of 
depression to 
treatment with AD 
drugs and indices of 
bipolarity found by 
other researchers. 
Kung, S. (2015). Screening 
for bipolar disorders: 
Clinical utilization of the 
mood disorders 
questionnaire on an 
None Stated. 
Donabedian 
Model 
inferred. 
Design: Controlled 
trial-intervention 
study. 
Purpose: Evaluate the 
N= 860 (1330 -284 for 
incomplete MDQ -135 
for recurrent 
admission-51 for other 
IV1-Ψ EVAL 
IV2-MDQ  
SCID 
MDQ 
JMP 10.0 Cutoff 6: 
SN=0.949, 
SP=0.561 
Cutoff 7: 
Clinical utilization of 
the MDQ as a 
screening instrument 
on the IP unit. 
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Depression, YR-Year 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
inpatient mood disorders 
unit.  
Population: Inpatient mood 
disorder clinic Mayo, 
Rochester, MN, USA 
Funding: Not Reported 
Bias: authors declare that 
they have no competing 
interests. 
LOE:III 
MDQ in an IP setting 
for clinical validation. 
Inclusion Criteria: PTS 
with a DC DG of 
UPD, MDD, DD NOS, 
DYS, or BP were 
included. 
Exclusion Criteria: 
Non-primary mood 
disorder were 
excluded. 
diagnosis) 
464 (54%)= 
Concurrence of 
symptoms and at least 
moderate severity 
234 + screens with 
cutoff of 7 
200 + screens with 
cutoff score of 8. 
DV1- Ψ DX  
DV2- MDQ 
score/ DX A 
 
SN=0.924, 
SP=0.639 
Cutoff 8: 
SN=0.856, 
SP=0.714,  
 
Outcomes suggest 
optimal OP MDQ 
cutoff of 7 and IP 
cutoff of 8. 
Purpose of a 
screening instrument 
is to alert and does 
not obviate the need 
for a thorough 
history and 
confirmatory steps of 
a diagnosis. 
Rucci, P. (2013). A review 
of self-report and 
interview-based 
instruments to assess 
mania and hypomania 
symptoms. 
Population: Adult MH 
Italy 
Funding: Not reported. 
Bias: Not reported 
None Stated.  Design/Method: 
Systematic search 
strategy devised and 
queried on Medline 
from 1973-2012. 
Purpose: overview of 
the self-report and 
interview-based 
instruments to assess 
mania/hypomania 
symptoms and related 
features. Focus on 
psychometric 
Sample: 43 Studies 
describing 31 
instruments, 17 self-
report and 14 
interview-based. 
IV1-Ψ 
instrument 
DV1-  internal 
consistency 
DV2- validity 
DV3-factor 
analysis 
DV4-inter-rater 
reliability 
Self-report 
questionnaires 
(MDQ,HCL-
32,BSDS,Mood 
Spectrum). 
 Interview-based 
instruments 
(YMRS, BRMAS) 
Factor analysis 
and latent 
structure 
analysis (Rasch 
analysis). 
Search terms: 
mania, 
hypomania, 
bipolar 
spectrum, mood 
spectrum, 
instrument, 
rating scale, 
questionnaire, 
MDQ SN=0.61, 
SP=0.87, 
PPV=0.58, 
NPV=0.88 
Cutoff of 6 
provided the 
best balance of 
SN=0.76 and 
SP=0.86 
Increasing the use of 
self-report 
instruments to screen 
BP in high-risk PTS 
presenting with 
depression may 
contribute to 
increasing the use of 
routine standardized 
assessment.  
Self-rating scales 
have an advantage of 
being able to assess 
the PTS internal 
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Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
LOE:I properties, pros/cons. 
Inclusion Criteria: 
published in a peer-
reviewed book or 
journal in English. 
Exclusion Criteria: Did 
not meet inclusion 
criteria. 
 interview and 
validity, 
reliability, 
psychometric 
properties 
 
states and avoid 
clinician 
misinterpretation. 
Leao, I. (2012). Cross 
validation with the mood 
disorder questionnaire 
(MDQ) of an instrument 
for the detection of 
hypomania in brazil:the 32 
item hypomania symptom 
check-list, first revision 
(Hcl-32-R1). Population: 
Psychiatric patient in 
Brazil 
Funding: None.  
Bias: Leao has no conflict 
of interest. Del Porto is a 
member of the 
international board of 
Lundbeck and a speaker 
None Stated. 
Donabedian 
Model 
inferred 
Design: RCT. Random 
selection.  
Purpose: Evaluation of 
scales to improve and 
simplify identification 
of BP 
Inclusion Criteria: 
adults, written consent. 
Exclusion Criteria: 
Those with 
schizophrenia and 
severe organic 
diseases. 
Setting: Psychiatric 
Outpatient. 
N=200 
F=80% 
M=20% 
AA=44 (16-73) 
BP spectrum=59.5%, 
cyclothymia=39% 
 
IV1- MDQ 
IV2-HCL-32-R1 
IV3—Ψ 
EVAL(SCID-
CV) 
DV1- MDQ 
Score/ DX A 
DV2- HCL-32-
R1 Score/ DX A 
DV3-Ψ DG  
HCL-32 
MDQ 
SCID 
Internal 
consistency 
evaluation using 
Cronbach’s 
alpha.  
Mann Whitney 
test and t-test. 
Varimax 
rotation was 
used to identify 
the factor 
structure of the 
MDQ scree test. 
MDQ SN=0.68, 
SP=0.63, 
AUC=0.723 
MDQ 
reproducibility 
is 0.69 
MDQ 1st 
administration 
=0.761 
Cronbach’s 
alpha 
2nd 
administration=
0.782 
Questionnaires 
represent a potential 
improvement in the 
clinicians’ ability to 
detect and correctly 
treat bipolar disorder. 
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Confidence Interval, CIDI-Composite International Diagnostic Interview, CL-Common Law, CP-Clinical Practice, DC-Discharge, DD NOS-Depressive Disorder Not Otherwise Specified,  DEP-
Depression, DEM-Dementia, DO-Disorder, DOI- Duration of Illness in Months, DOR-Diagnostic Odds Ratios, DV1-Dependent Variable 1, DV2-Dependent Variable 2, DX- Diagnosis, DYS- 
Dysthymia, ED-Education, EVAL-Evaluation, F-Female, FHX-Family History, FU-Follow Up, HAM- Hamilton Depression Rating Scale, HCL-32- Hypomania Checklist-32, HS- High School, 
HSROC-Hierarchical Summary Receiver Operating Characteristics, IC-Informed Consent, IP- Inpatient, IV1-Independent Variable 1,IV2- Independent Variable 2, LOE-Level of Evidence, LOED- 
Level of Education, M- Male, MA-Married, MDD- Major Depressive Disorder, MDE-Major Depressive Episode, MDQ- Mood Disorder Questionnaire, MDQ-C- Mood Disorder Questionnaire Chinese 
Version, MED-Medical Disorder, MH-Mental Health, MINI- Mini Neuropsychological Interview, MR- Mental Retardation, MS-Marital Status, N-Number, NESDA-Netherlands Study of Depression 
and Anxiety, NOHRD- Netherlands Organization for Health Research and Development, NPV-Negative Predictive Value, OA-Onset Age, OCD-Obsessive Compulsive Disorder, ORG-Organic 
Disorder, OP-Outpatient, PG-Pregnant, PP- Postpartum,,PPV-Positive Predictive Value, PSYCH- Psychotic Disorder, PTS-Patients, Q-Questionnaire, QOL-Quality of Life, QUADAS 2- Quality 
Assessment of Diagnostic Accuracy Studies-2, ROC- Receiver Operating Characteristic, S- Single, SCID- Standard Clinical Interview for DSM Disorders,SD-Standard Deviation, SEIFA- Socio-
Economic Index for Areas, SN- Sensitivity, SP- Specificity, SSPS- Statistical Package for the Social Sciences, SUB- Substance Disorder, TR-Treatment Resistant,UN- University Degree, UPD-Unipolar 
Depression, YR-Year 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use 
in Practice/ 
Application to 
Practice 
for pharmaceuticals 
LOE:II 
 
Dodd, S. (2009). 
Reliability of the mood 
disorder questionnaire: 
comparison with the 
structured clinical 
interview for the DSM-IV-
TR in a population sample. 
Population: Women 
included in a large 
epidemiological study in 
Australia. 
Funding:Not reported 
Bias:None reported 
LOE:II 
None Stated. Design: RCT. 
Intervention study. 
Purpose: Investigate 
reliability of the MDQ 
Inclusion Criteria: age 
21-94, women, written 
consent 
 
Exclusion Criteria: 
lack of participation in 
the clinical interview 
or MDQ scale, 
inability to provide 
consent, death, 
inability to be 
contacted. 
Initial Sample: 
N=1494 women 
AA=54 years (21-94) 
FU Sample (10 yrs): 
N=1066 
AA=51(34-66) 
Education: primary 41 
(3.8%), part secondary 
444 (41.7%), 
secondary 271 (25.4%) 
Psychotropic use: 150 
(14.1%) 
Smoking: 150 (14.1%) 
IV1-Ψ EVAL/ 
(SCID-I) 
IV2-MDQ 
DV1- Ψ DX 
DV2- MDQ 
score/ DX A 
 
Status assessed with 
the SCID-I 
MDQ 
SEIFA index score 
Minitab version 
15. Manual 2x2 
table of 
association. 
MDQ SN=0.25, 
SP=0.99, 
PPV=0.28, 
NPV=0.98, 
Kappa=0.25 
Results for the MDQ 
SN and SP vary 
greatly depending on 
PT population. 
Reliable screening 
tools to detect BP in 
clinical and 
community 
populations are of 
overt value and the 
development of 
novel tools and 
refinement of 
existing instruments 
is warranted. 
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Ψ EVAL- Psychiatric Evaluation, AOI- Age of Onset of Illness, BP- Bipolar, BSDS- Bipolar Spectrum Diagnostic Scale, CIDI-Composite International Diagnostic 
Interview, FHX-Family History, GP- General Practice, HAM-Hamilton Rating Scale, HCL-32-Hypomania Checklist-32, IP- Inpatient, LOE- Level of Evidence, MA- 
Meta Analysis, MDQ- Mood Disorder Questionnaire, N- Number,NR- Not Reported,  OP- Outpatient, S- Studies, SCID- Structured Clinical Interview for the DSM-
IV, SN- Sensitivity, SP-Specificity, SR- Systemic Review 
 
 
Appendix B 
Synthesis Table: MDQ Screening for Bipolar Disorder 
 
Author 
 
Wang 
 
Frey 
 
Boschloo 
 
Gan 
 
Poon 
 
Lin 
 
Lee 
 
Rybakowski 
 
Kung 
 
Ricci 
 
Leao 
 
Dodd 
Study Characteristics 
Year 2015 2012 2013 2012 2011 2011 2013 2012 2015 2013 2012 2009 
LOE I III II III II II II II III I II II 
Country World-
wide 
Cana
da 
Nether-
lands 
China China Taiwan Korea Poland USA Italy Brazil Australia 
Setting IP/OP OP OP IP OP OP IP/OP OP IP IP/OP OP OP 
Population Demographics 
Sample             
N NR (21 S) 150 2087 142 305 170 113 1051 133 SR 200 1066 
Mean Age NR 30.1 44.7 28.6 50.0 38.94 38.2 18.7 40.7 SR 44.0 54.0 
Female Gender(%)  NR 100 66.6 45.7 66.9 57.06 66.2 71.3 65.6 SR 59.5 100 
BP Excluded X (7 S)    X      X  
BP Included X (14 S) X X X  X X X X X  X 
Independent Variables 
SCID/ Ψ EVAL   X X     X  X X 
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Ψ EVAL- Psychiatric Evaluation, AOI- Age of Onset of Illness, BP- Bipolar, BSDS- Bipolar Spectrum Diagnostic Scale, CIDI-Composite International Diagnostic 
Interview, FHX-Family History, GP- General Practice, HAM-Hamilton Rating Scale, HCL-32-Hypomania Checklist-32, IP- Inpatient, LOE- Level of Evidence, MA- 
Meta Analysis, MDQ- Mood Disorder Questionnaire, N- Number,NR- Not Reported,  OP- Outpatient, S- Studies, SCID- Structured Clinical Interview for the DSM-
IV, SN- Sensitivity, SP-Specificity, SR- Systemic Review 
 
 
Author 
 
Wang 
 
Frey 
 
Boschloo 
 
Gan 
 
Poon 
 
Lin 
 
Lee 
 
Rybakowski 
 
Kung 
 
Ricci 
 
Leao 
 
Dodd 
MDQ X X X X X X X X X X X X 
CIDI  X           
BSDS       X      
HCL-32     X   X  X X  
MINI      X       
  Measurable Outcomes  
SN(%) 89 83 89 72 65 85 74 NR 86 61 68 73 
SP(%) 84 82 84 73 77 87 84 NR 71 87 63 90 
Optimal MDQ 
Score Cutoff 
            
≥7 X X X    X  X X X X 
<7    X X (4+) X (6)  X     
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